Systemic vasculitis

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia
Kornelis S M van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Jan 2020, annrheumdis-2019-216343; DOI: 10.1136/annrheumdis-2019-216343
Harmonisation of laboratory tests for rheumatic diseases: still a long way to go
Lieve Van Hoovels, Xavier Bossuyt

Annals of the Rheumatic Diseases Jan 2020, 79 (1) e5; DOI: 10.1136/annrheumdis-2018-214696
Correspondence to ‘Slope sign’: a feature of large vessel vasculitis?
Marcin Milchert, Marek Brzosko, Anne Bull Haaversen, Andreas P Diamantopoulos

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216601; DOI: 10.1136/annrheumdis-2019-216601
Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients
Maria Letizia Urban, Federica Maritati, Alessandra Palmisano, Paride Fenaroli, Francesco Peyronel, Giorgio Trivioli, Stefania Ferretti, Consuelo De Biase, Peter C Grayson, Francesco Pegoraro, Domenico Prisco, Paola Romagnani, Giacomo Emmi, Augusto Vaglio

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216258; DOI: 10.1136/annrheumdis-2019-216258
‘MAINRITSAN2-the future’, with some doubts!
Arghya Chattopadhyay, Nupoor Acharya, Debashish Mishra, Vikas Sharma, GSRSNK Naidu, Aman Sharma

Annals of the Rheumatic Diseases Dec 2019, 78 (12) e139; DOI: 10.1136/annrheumdis-2018-214486
Response to: ‘“MAINRITSAN2-the future”, with some doubts!’ by Chattopadhyay et al
Pierre Charles, Loic Guillevin

Annals of the Rheumatic Diseases Dec 2019, 78 (12) e140; DOI: 10.1136/annrheumdis-2018-214516
Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis
Sebastian Klapa, Antje Müller, Andreas Koch, Harald Heidecke, Wataru Kähler, Juliane Junker, Susanne Schinke, Gabriela Riemekasten, Peter Lamprecht

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1443-1444; DOI: 10.1136/annrheumdis-2019-215341
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study
Carlotta Nannini, Laura Niccoli, Stelvio Sestini, Iashar Laghai, Angela Coppola, Fabrizio Cantini

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1444-1446; DOI: 10.1136/annrheumdis-2019-215585
Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: a French multicentre retrospective study
Thomas Bettuzzi, Alban Deroux, Marie Jachiet, Meryem-Maud Farhat, julien wipff, Marc Fabre, Laurence Bouillet, Nora Kramkimel, Selim Aractingi, Nicolas Dupin, Benjamin Terrier

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1446-1448; DOI: 10.1136/annrheumdis-2019-215605
Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated
Nikolai Bulanov, Natalia V Chebotareva, Pavel I Novikov, Sergey V Moiseev

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e111; DOI: 10.1136/annrheumdis-2018-214095

Main menu

Systemic vasculitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic vasculitis

Pages